Meeting
2017 ASCO Annual Meeting
Impact of prior radiation on survival in metastatic lung cancer ECOG-ACRIN trials.
Authors
Saad A. Khan
The University of Texas Southwestern Medical Center, Dallas, TX
Saad A. Khan , Maneka Puligandla , Suzanne Eleanor Dahlberg , Gregory A. Masters , Corey J. Langer , Julie R. Brahmer , Nasser H. Hanna , Philip Bonomi , David E. Gerber , David H. Johnson , Joan H. Schiller , Suresh S. Ramalingam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 9051)
DOI
10.1200/JCO.2017.35.15_suppl.9051
Abstract #
9051
Poster Bd #
377
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Association of progression-free survival and overall response rate with overall survival in first-line randomized trials of immune checkpoint inhibitor–based regimens for metastatic non–small cell lung cancer (NSCLC): An FDA pooled analysis.
First Author: Bernardo Haddock Lobo Goulart
Poster
2021 ASCO Annual Meeting
Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
First Author: Lingbin Meng
Poster
2021 ASCO Annual Meeting
Population-based impacts of new therapies on outcomes for stage IV non-small cell lung cancer.
First Author: Rebekah Rittberg
Poster
2020 ASCO Virtual Scientific Program
An FDA analysis of the association of tumor growth rate and overall and progression-free survival in metastatic non-small cell lung cancer (NSCLC) patients.
First Author: Yutao Gong